Ketamine, a schedule III drug, is often used recreationally for its hallucinogenic effects. Its approved purpose, however, is as an anesthetic in medical settings for animals and humans. Recently, it has also been approved by the FDA to treat major depressive disorder in patients who are resistant to other treatments. [Read More…]
Search Results for author "Shelby Deegan"
The McGill Journal of Sustainable Development Law hosted a webinar on the impacts of COVID-19 on mobility policy in the European Union (EU) on Nov. 12. The featured speaker was Iris Goldner Lang, a professor of EU Law at the University of Zagreb in Croatia. Emma Sitland, 2L Law and[Read More…]
On Sept. 16, the Trottier Institute for Sustainability in Engineering and Design held its seventh annual symposium titled “Lessons from a Pandemic: Solutions for Addressing the Climate Change Crisis.” The first speaker, Dr. Naomi Oreskes, an affiliated professor of Earth and Planetary Sciences at Harvard University, discussed why people should[Read More…]